MYSTERIOUS: 12 | Mind Blowing Facts

India’s GLP-1 Weight Loss Drug Problem Nobody Is Warning You About

A 26-year-old marketing executive in Mumbai loses 14 kilos in three months. Her Instagram fills with compliments. Friends ask for her “secret.” She smiles and says it is just discipline and calorie control. What she does not mention is the weekly injection sitting inside her refrigerator. Across India, GLP-1 drugs…

MyLifeXP · May 29

Understanding Visceral Fat Health and Why Belly Fat Is a Serious Obesity Risk

Learn how visceral fat differs from subcutaneous fat, why belly fat increases obesity risk, and how improving visceral fat health supports long term disease prevention.

Medical Daily · May 27

Greece becomes a model country against childhood obesity with UNICEF's help

The results of the initiatives in Greece to tackle childhood obesity have been presented, showing outstanding progress.

Euronews · May 27

Ebola Response Efforts in Africa Threatened by US Aid Cuts, Experts Warn

Ebola remains one of the world's most dangerous infectious diseases, with outbreaks in Central and East Africa repeatedly straining already fragile healthcare systems. And with the recent cuts to United States foreign aid, public health experts are raising concerns that could weaken Ebola surveillance and response efforts in parts of…

Medical Daily · May 24

Is the End of the Obesity Epidemic Near? People Lost Up to 85 Pounds Using New Weight Loss Drug

Eli Lilly's retatrutide is a significant advance on the promising results from drugs like Ozempic and Wegovy.

Reason · May 22

Why Wall Street Thinks This Dividend Stock Could Jump 30%

Amgen stock could offer attractive long-term upside for investors willing to ride through near-term volatility.

Barchart · May 22

How does your body lose weight? An obesity doctor explains why one size doesn’t fit all in weight loss

For decades, people have been told that their weight problems can be solved by math: Calories in, calories out. If weight were a simple math equation, more people would likely be the weight they desire. But it is much more complicated.

The Conversation · May 22

Corbus Pharmaceuticals Teases Key ASCO Cancer Data, Late-Summer Obesity Readout

Corbus Pharmaceuticals (NASDAQ:CRBP) Chief Executive Officer Yuval Cohen said investors should expect more mature clinical updates for CRB-701 at the upcoming ASCO meeting, including the first durability and progression-free survival data for the company’s highlighted cervical and head and neck canc

MarketBeat · May 22

New weight-loss shot appears to outperform other obesity drugs on market

Eli Lilly says participants in a sizable trial of retatrutide lost much more weight compared to other weight-loss drugs

The Guardian - US · May 21

Health experts hit out at Reeves’ snack food price cuts: ‘We’re in an obesity crisis’

Biscuits, chocolate and baked beans could become cheaper as the government slashes import tariffs on more than 100 types of product

The Independent UK · May 21